Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) Stock Price, News & Analysis

Company Overview

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., commonly known as Gedeon Richter, is a Hungarian multinational pharmaceutical company with roots dating back to 1901. Founded by pharmacist Gedeon Richter in Budapest, the company has grown into one of Central Europe’s leading drug manufacturers. Over more than a century of operation, Richter has established a strong reputation for both proprietary drug discovery and the development of high-quality generic medicines.

Richter’s principal business activities encompass research and development, production and marketing of pharmaceutical products. The company is particularly active in women’s healthcare, with products for contraception and hormone replacement therapy. In addition, Richter develops medicines targeting the central nervous system—such as treatments for depression and schizophrenia—as well as cardiovascular therapies. In recent years, the company has also expanded its portfolio to include biosimilar products and ophthalmology treatments.

From its headquarters in Budapest, Richter manages a global manufacturing and distribution network, exporting to more than 100 countries worldwide. While its strongest market presence remains in Central and Eastern Europe, the company has built significant operations and partnerships across Western Europe, the Commonwealth of Independent States, and select markets in Asia and Latin America. Its production facilities combine state-of-the-art technology with stringent quality controls to meet international regulatory standards.

Richter is overseen by a board of directors and executive management team with extensive experience in pharmaceutical development and international business. The company maintains close collaborations with academic institutions, contract research organizations and other industry partners to support its innovation pipeline. Through ongoing investment in research, Richter remains committed to addressing unmet medical needs and strengthening its position in both branded and generic pharmaceutical markets.

Key Stats

• Today's Range: $40.98 to $42.21
• 50-Day Range: $31.00 to $45.28
• 52-Week Range: $29.00 to $45.28
• Volume: 20 shs
• Average Volume: 1,658 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RGEDF Stock Analysis - Frequently Asked Questions

How have RGEDF shares performed this year?

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s stock was trading at $31.00 on January 1st, 2026. Since then, RGEDF stock has increased by 32.2% and is now trading at $40.9787.

How do I buy shares of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.?

Shares of RGEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/05/2026
• Next Earnings (Estimated): 5/12/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RGEDF
• CIK: N/A
• Web: www.richter.hu
• Phone: 36.1.431.4000
• Fax: N/A
• Employees: 11,603
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A